Dry mouldable drug formulation
US7666844B2 · kind B2 · utility
17Cited by
69References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2005 |
| Grant date | Feb 23, 2010 |
| Priority date | — |
| Expiry date | Nov 13, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.